ACAN and Hyperglycemia: Moreover, the addition of a high glucose level to PA at 0.1 mM further supported the trend of PA to decrease the mRNA level of aggrecan previously found under normoglycemic conditions (p = 0.015 between PA-treated cells under normo- and hyperglycemia).